Concepedia

Donald C. Porter

DC

16

Publications

1.2K

Citations

13

H-Index

1986

Active since

Affiliations

Senex Biotechnology (United States)(Current)

University of South Carolina

Wadsworth Center

University of California San Diego

University at Albany, State University of New York

Donald C. Porter is an author at Senex Biotechnology (United States) specializing in medicine, cell biology, and epigenetics.

Top concepts

Publications per year

1986–2024

16

Publications

16

Lovastatin-mediated G <sub>1</sub> arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

Sharmila Rao, Donald C. Porter, Xiaomei Chen et al. · Proceedings of the National Academy of Sciences · 1999 · 347 citations · Full text

Tumor-Specific Proteolytic Processing of Cyclin E Generates Hyperactive Lower-Molecular-Weight Forms

Donald C. Porter, Ning Zhang, Christopher G. Danes et al. · Molecular and Cellular Biology · 2001 · 197 citations · Full text

Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities

Donald C. Porter, Elena Farmaki, Serena Altilia et al. · Proceedings of the National Academy of Sciences · 2012 · 175 citations · Full text

, , +11

CDK8/19 Mediator kinases potentiate induction of transcription by NFκB

Mengqian Chen, Jiaxin Liang, Hao Ji et al. · Proceedings of the National Academy of Sciences · 2017 · 134 citations · Full text

Processing of cyclin E differs between normal and tumor breast cells.

Richard M. Harwell, Donald C. Porter, Christopher G. Danes et al. · PubMed · 2000 · 101 citations

, , +13

Rows per page

1–5 of 16